Gaudenzia Names Dr. Philip Moore as First Chief Medical Officer

Business News
Physician will seek to unify medical services throughout the organization

NORRISTOWN, PA — Gaudenzia, Inc., the region’s leading nonprofit provider of treatment for substance use disorders, this week named Dr. Philip Moore its first Chief Medical Officer, as the organization seeks to bring greater standardization to its medical protocols and processes across Washington, DC and the three states that it serves.

Dr. Moore is a leading expert in SUD treatment and toxicology and has served as medical director for Gaudenzia’s Central and Western regions in Pennsylvania since October 2020. The move underscores the critical importance of Medication Assisted Treatment and other healthcare-related programs for Gaudenzia’s clients in its 51 facilities across Pennsylvania, Maryland and Delaware, as well as its RAP, Inc., subsidiary in Washington D.C.

“Dr. Moore brings the expertise and passion needed to further strengthen Gaudenzia’s wide array of health and medical services,” said Chief Executive Officer Dr. Dale Klatzker. “He has years of experience on the front lines of the opioid and stimulant epidemics afflicting our communities and is deeply committed to developing and upholding the highest standard of innovative care for our clients.”

READ:  Unlimited Technology Adds Security Executives to Leadership Team

Among Dr. Moore’s initial priorities will be the standardization of admissions criteria throughout Gaudenzia’s footprint. This step will help reduce the barriers for medical clearance during the admission process, which will reduce wait times, especially when calling the 24-hour treatment and referral HelpLine. He will also be focused on Medication Assisted Treatment across the regions, including programs for pregnant, post-partum and breastfeeding women, as well as MAT training for staff and consultants.

Dr. Moore will oversee a team of more than 100 medical professionals, who work with clients in Gaudenzia’s facilities.

“The paradigm of accessing medicine is fraught with uncertainty. This process is intensified for persons seeking addiction treatment because of stigma and past experiences, amongst other factors,” Dr. Moore said. “My goal is for Gaudenzia to be named in conversation when someone asks their neighbor, family, friend, co-worker for a recommendation for help and whom they would trust their loved ones to for treatment.”

READ:  Celebrating 20 Years at Shell, International Geoscience Expert Reaches Major Milestone

Dr. Moore said his first priority is to unify medical services, starting with detoxification or withdrawal management within the organization.

“Treatment often starts in detox, so it is logical to initially focus my efforts within these facilities throughout the organization,” he said.

Dr. Moore received his doctorate of osteopathic medicine from Michigan State University. He also holds a bachelor of science degree in Briggs Physiology with a specialization in health and humanities from Michigan State.

Dr. Moore served a residency at Maine Medical Center/Tufts University School of Medicine in Portland, ME, and had a medical toxicology fellowship at the PinnacleHealth/Penn State University College of Medicine, Harrisburg Hospital. He has more than 15 years of experience in both rural and urban healthcare systems in inpatient, outpatient, primary and tertiary, academic and private practice environments.

READ:  Timoney Knox Acquires Davis Bennett Spiess & Livingood LLC

Additional information about Gaudenzia’s programs can be found at www.gaudenzia.org. Those who are in need of treatment can call Gaudenzia’s 24/7 Treatment and Recovery Helpline at 833-976-HELP (4357).

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.